CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/53154 |
Resumo: | OBJECTIVES: We investigated four components of the Wnt signaling pathway in medulloblastomas. Medulloblastoma is the most common type of malignant pediatric brain tumor, and the Wnt signaling pathway has been shown to be activated in this type of tumor. METHODS: Sixty-one medulloblastoma cases were analyzed for β-catenin gene (CTNNB1) mutations, β-catenin protein expression via immunostaining and Wnt signaling pathway-related gene expression. All data were correlated with histological subtypes and patient clinical information. RESULTS: CTNNB1 sequencing analysis revealed that 11 out of 61 medulloblastomas harbored missense mutations in residues 32, 33, 34 and 37, which are located in exon 3. These mutations alter the glycogen synthase kinase-3β phosphorylation sites, which participate in β-catenin degradation. No significant differences were observed between mutation status and histological medulloblastoma type, patient age and overall or progression-free survival times. Nuclear β-catenin accumulation, which was observed in 27.9% of the cases, was not associated with the histological type, CTNNB1 mutation status or tumor cell dissemination. The relative expression levels of genes that code for proteins involved in the Wnt signaling pathway (CTNNB1, APC, AXIN1 and WNT1) were also analyzed, but no significant correlations were found. In addition, large-cell variant medulloblastomas presented lower relative CTNNB1 expression as compared to the other tumor variants. CONCLUSIONS: A small subset of medulloblastomas carry CTNNB1 mutations with consequent nuclear accumulation of β-catenin. The Wnt signaling pathway plays a role in classic, desmoplastic and extensive nodularity medulloblastoma variants but not in large-cell medulloblastomas. |
id |
USP-19_b557de591ae121b375c1a05f182b66f5 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/53154 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants Gene ExpressionImmunohistochemistryMedulloblastomaWnt Pathway OBJECTIVES: We investigated four components of the Wnt signaling pathway in medulloblastomas. Medulloblastoma is the most common type of malignant pediatric brain tumor, and the Wnt signaling pathway has been shown to be activated in this type of tumor. METHODS: Sixty-one medulloblastoma cases were analyzed for β-catenin gene (CTNNB1) mutations, β-catenin protein expression via immunostaining and Wnt signaling pathway-related gene expression. All data were correlated with histological subtypes and patient clinical information. RESULTS: CTNNB1 sequencing analysis revealed that 11 out of 61 medulloblastomas harbored missense mutations in residues 32, 33, 34 and 37, which are located in exon 3. These mutations alter the glycogen synthase kinase-3β phosphorylation sites, which participate in β-catenin degradation. No significant differences were observed between mutation status and histological medulloblastoma type, patient age and overall or progression-free survival times. Nuclear β-catenin accumulation, which was observed in 27.9% of the cases, was not associated with the histological type, CTNNB1 mutation status or tumor cell dissemination. The relative expression levels of genes that code for proteins involved in the Wnt signaling pathway (CTNNB1, APC, AXIN1 and WNT1) were also analyzed, but no significant correlations were found. In addition, large-cell variant medulloblastomas presented lower relative CTNNB1 expression as compared to the other tumor variants. CONCLUSIONS: A small subset of medulloblastomas carry CTNNB1 mutations with consequent nuclear accumulation of β-catenin. The Wnt signaling pathway plays a role in classic, desmoplastic and extensive nodularity medulloblastoma variants but not in large-cell medulloblastomas. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2013-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/5315410.6061/CLINICS/2013(02)OA08Clinics; Vol. 68 No. 2 (2013); 167-172 Clinics; v. 68 n. 2 (2013); 167-172 Clinics; Vol. 68 Núm. 2 (2013); 167-172 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/53154/57215Silva, Roseli daMarie, Suely K. N.Uno, MiyukiMatushita, HamiltonWakamatsu, AldaRosemberg, SergioOba-Shinjo, Sueli M.info:eu-repo/semantics/openAccess2013-04-08T20:40:36Zoai:revistas.usp.br:article/53154Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2013-04-08T20:40:36Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants |
title |
CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants |
spellingShingle |
CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants Silva, Roseli da Gene Expression Immunohistochemistry Medulloblastoma Wnt Pathway |
title_short |
CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants |
title_full |
CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants |
title_fullStr |
CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants |
title_full_unstemmed |
CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants |
title_sort |
CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants |
author |
Silva, Roseli da |
author_facet |
Silva, Roseli da Marie, Suely K. N. Uno, Miyuki Matushita, Hamilton Wakamatsu, Alda Rosemberg, Sergio Oba-Shinjo, Sueli M. |
author_role |
author |
author2 |
Marie, Suely K. N. Uno, Miyuki Matushita, Hamilton Wakamatsu, Alda Rosemberg, Sergio Oba-Shinjo, Sueli M. |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Silva, Roseli da Marie, Suely K. N. Uno, Miyuki Matushita, Hamilton Wakamatsu, Alda Rosemberg, Sergio Oba-Shinjo, Sueli M. |
dc.subject.por.fl_str_mv |
Gene Expression Immunohistochemistry Medulloblastoma Wnt Pathway |
topic |
Gene Expression Immunohistochemistry Medulloblastoma Wnt Pathway |
description |
OBJECTIVES: We investigated four components of the Wnt signaling pathway in medulloblastomas. Medulloblastoma is the most common type of malignant pediatric brain tumor, and the Wnt signaling pathway has been shown to be activated in this type of tumor. METHODS: Sixty-one medulloblastoma cases were analyzed for β-catenin gene (CTNNB1) mutations, β-catenin protein expression via immunostaining and Wnt signaling pathway-related gene expression. All data were correlated with histological subtypes and patient clinical information. RESULTS: CTNNB1 sequencing analysis revealed that 11 out of 61 medulloblastomas harbored missense mutations in residues 32, 33, 34 and 37, which are located in exon 3. These mutations alter the glycogen synthase kinase-3β phosphorylation sites, which participate in β-catenin degradation. No significant differences were observed between mutation status and histological medulloblastoma type, patient age and overall or progression-free survival times. Nuclear β-catenin accumulation, which was observed in 27.9% of the cases, was not associated with the histological type, CTNNB1 mutation status or tumor cell dissemination. The relative expression levels of genes that code for proteins involved in the Wnt signaling pathway (CTNNB1, APC, AXIN1 and WNT1) were also analyzed, but no significant correlations were found. In addition, large-cell variant medulloblastomas presented lower relative CTNNB1 expression as compared to the other tumor variants. CONCLUSIONS: A small subset of medulloblastomas carry CTNNB1 mutations with consequent nuclear accumulation of β-catenin. The Wnt signaling pathway plays a role in classic, desmoplastic and extensive nodularity medulloblastoma variants but not in large-cell medulloblastomas. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/53154 10.6061/CLINICS/2013(02)OA08 |
url |
https://www.revistas.usp.br/clinics/article/view/53154 |
identifier_str_mv |
10.6061/CLINICS/2013(02)OA08 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/53154/57215 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 68 No. 2 (2013); 167-172 Clinics; v. 68 n. 2 (2013); 167-172 Clinics; Vol. 68 Núm. 2 (2013); 167-172 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222759723204608 |